Evaluation of NLRC4, NLRP1, and NLRP3, as Components of Inflammasomes, in Chronic Hepatitis B Virus-Infected Patients

Viral Immunology

Volumn 29, Issue 9, 2016, Pages 496-501

  Askari, Azadeh ^a   Nosratabadi, Reza ^a   Khaleghinia, Mehdi ^b   Zainodini, Nahid ^a   Kennedy, Derek ^c   Shabani, Ziba ^a   Arababadi, Mohammad Kazemi ^a  

^a RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c GRIFFITH UNIVERSITY   (Australia)

Author keywords

chronic HBV infection; inflammasome; NLRC4; NLRP1; NLRP3 PRR; NLRs

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BETA ACTIN; BILIRUBIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; INFLAMMASOME; MESSENGER RNA; NLR FAMILY CARD DOMAIN CONTAINING PROTEIN 4; NUCLEOTIDE BINDING DOMAIN LEUCINE REPEAT 1; NUCLEOTIDE BINDING DOMAIN LEUCINE REPEAT 3; NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; ALANINE AMINOTRANSFERASE; APOPTOSIS REGULATORY PROTEIN; BIOLOGICAL MARKER; CALCIUM BINDING PROTEIN; CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN; CRYOPYRIN; NLRC4 PROTEIN, HUMAN; NLRP1 PROTEIN, HUMAN; NLRP3 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; VIRUS DNA;

ADULT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CASE CONTROL STUDY; CHRONIC HEPATITIS B; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE DOSAGE; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; LIMIT OF QUANTITATION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS LOAD; BLOOD; HEPATITIS B VIRUS; IMMUNOLOGY; ISOLATION AND PURIFICATION; LIVER; METABOLISM; MONOCYTE; PATHOLOGY; VIROLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; ALANINE TRANSAMINASE; APOPTOSIS REGULATORY PROTEINS; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; BIOMARKERS; CALCIUM-BINDING PROTEINS; CARD SIGNALING ADAPTOR PROTEINS; CASE-CONTROL STUDIES; DNA, VIRAL; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INFLAMMASOMES; LIVER; LIVER FUNCTION TESTS; MALE; MONOCYTES; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; VIRAL LOAD;

EID: 84994614059     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2016.0045     Document Type: Article

References (24)

1. Arababadi MK, Pourfathollah AA, Jafarzadeh A, et al. Association of exon 9 but not intron 8 VDR polymorphisms with occult HBV infection in south-eastern Iranian patients. J Gastroenterol Hepatol 2009;25:90-93.
2. Assar A, Arababadi MK, Mohit M, et al. T helper and B cell escape mutations within the HBc gene in patients with asymptomatic HBV infection: a study from the South-Eastern region of Iran. Clin Lab 2012;58:53-60.
3. Ayoobi F, Hassanshahi G, Zainodini N, et al. Reduced expression of TRIF in chronic HBV infected Iranian patients. Clin Res Hepatol Gastroenterol 2013;37:491-495.
4. Chan HL, and Jia J. Chronic hepatitis B in Asia-new insights from the past decade. J Gastroenterol Hepatol 2011; 26 Suppl 1:131-137.
5. Dinarello C. The IL-1 family and inflammatory diseases. Clin Exp Rheumatol 2002;20:S1-S13.
6. Ebrahim M, Mirzaei V, Bidaki R, et al. Are RIG-1 and MDA5 expressions associated with chronic HBV infection? Viral Immunol 2015;28:504-508.
7. Feitelson MA. Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinoma. Cancer Lett 2006;239:10-20.
8. Franchi L, and Núñez G. The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1b secretion but dispensable for adjuvant activity. European J Immunol 2008;38:2085-2089.
9. Hassanshahi G, Sajadi SMA, Mirzaei V, et al. Expressions of ASC and caspase-1 but not AIM2 are disrupted in chronic HBV infected patients. Asian Pac J Trop Dis 2014; 4:301-305.
10. Jin C, and Flavell RA. Innate sensors of pathogen and stress: linking inflammation to obesity. J Allergy Clin Immunol 2013;132:287-294.
11. Karimi-Googheri M, Daneshvar H, Khaleghinia M, et al. Decreased expressions of STING but not IRF3 molecules in chronic HBV infected patients. Arch Iran Med 2015;18: 351-354.
12. Latz E, Xiao TS, and Stutz A. Activation and regulation of the inflammasomes. Nat Rev Immunol 2013;13:397-411.
13. Liu HG, Chen WW, Fan ZP, et al. The high prevalence of the I27 mutant HBcAg18-27 epitope in Chinese HBVinfected patients and its cross-reactivity with the V27 prototype epitope. Clin Immunol 2007;125:337-345.
14. Manigold T, Böcker U, Chen J, et al. Hepatitis B core antigen is a potent inductor of interleukin-18 in peripheral blood mononuclear cells of healthy controls and patients with hepatitis B infection. J Med Virol 2003;71:31-40.
15. Momeni M, Zainodini N, Bidaki R, et al. Decreased expression of toll like receptor signaling molecules in chronic HBV infected patients. Hum Immunol 2013;137:1674-1679.
16. Negash AA, Ramos HJ, Crochet N, et al. IL-1beta production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathog 2013;9:e1003330.
17. Sagulenko V, Thygesen S, Sester D, et al. AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC. Cell Death Differ 2013; 20:1149-1160.
18. Sajadi SM, Mirzaei V, Hassanshahi G, et al. Decreased expressions of toll-like receptor 9 and its signaling molecules in chronic hepatitis B virus-infected patients. Arch Pathol Lab Med 2013;137:1674-1679.
19. Takacs J, Kelly JA, PT T, et al. Effects of stigmatization on gay men living with HIV/AIDS in a Central-Eastern European context: a qualitative analysis from Hungary. Sex Res Social Policy 2013;10:24-34.
20. Wen H, Miao EA, and Ting JP. Mechanisms of NOD-like receptor-associated inflammasome activation. Immunity 2013;39:432-441.
21. Williams A, Flavell RA, and Eisenbarth SC. The role of NOD-like receptors in shaping adaptive immunity. Curr Opin Immunol 2010;22:34-40.
22. Wu DL, Xu GH, Lu SM, et al. Correlation of AIM2 expression in peripheral blood mononuclear cells from humans with acute and chronic hepatitis B. Hum Immunol 2013;74:514-521.
23. Zhang Q, and Cao G. Genotypes, mutations, and viral load of hepatitis B virus and the risk of hepatocellular carcinoma: HBV properties and hepatocarcinogenesis. Hepat Mon 2011;11:86-91.
24. Zhang Y, Li Y, Ma Y, et al. Dual effects of interleukin-18: inhibiting hepatitis B virus replication in HepG2. 2.15 cells and promoting hepatoma cells metastasis. Am J Physiol-Gastrointest Liver Physiol 2011;301:G565-G573.